The cost-effectiveness of HLA-B*5801 screening to guide initial urate-lowering therapy for gout in the United States - Concepedia

Concepedia

Publication | Open Access

The cost-effectiveness of HLA-B*5801 screening to guide initial urate-lowering therapy for gout in the United States

DOI Full Paper Access

77

Citations

28

References

2016

Year

Eric Jutkowitz, Maureen Dubreuil, Na Lu, Karen M. Kuntz, Hyon K. Choi

Seminars in Arthritis and Rheumatism

Urological ResearchUrologyGouty ArthritisOutcomes ResearchUrogynecologyMedicineUnited StatesInitial Urate-lowering Therapy

References

	Year	Citations

Page 1